NOTES TO THE ANNUAL FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2007

       
« Note 22 Note 24 »
       
23. CASH FLOW INFORMATION    
    CONSOLIDATED THE COMPANY 
    2007 2006 2007 2006
    R million  R million R million  R million
  23.1 Adjustments         
Depreciation, amortisation of goodwill and trade marks  237  302  –  – 
Movement in provisions  (58) 65  –  – 
Interest received  (334) (341) –  – 
Finance cost  30  29  –  – 
Dividends received  (156) (410) (3 358) (4 191)
Capital surplus on the sale of investments  (7) (3 161) –  – 
Net impairment of assets  –  (3) –  – 
Share scheme cost  18  18  –  – 
Negative goodwill  (44) –  –  – 
Exchange rate gain/(loss) on foreign cash  622  (85) –  – 
Other  (2) –  – 
  309  (3 588) (3 358) (4 191)
23.2 Decrease/(increase) in working capital         
Decrease/(increase) in inventories and biological agricultural         
assets  (180) (139) –  – 
Decrease/(increase) in trade and other receivables  (109) (121) (1) (4)
Increase/(decrease) in trade and other payables  86  252 
Net movement in derivative instruments  33  (33) –  – 
  (170) (41) (2)
23.3 Reconciliation of dividends received         
Receivable at the beginning of the year  –  129  –  – 
Per income statement  156  410  3 358  4 191 
Dividends from associated companies set off against         
   investments  2 748  3 349     
Receivable at the end of the year  (168) –  –  – 
Cash received  2 736  3 888  3 358  4 191 
23.4 Reconciliation of taxation paid with the amount         
        disclosed in the income statement         
Paid in advance at the beginning of the year  67  60  –  – 
Unpaid at the beginning of the year  (473) (69) –  – 
Per income statement  (360) (854) –  – 
– normal income  (339) (491) –  – 
– capital gain  –  (350) –  – 
– STC  (21) (13) –  – 
Medi-Clinic  –  91  –  – 
Business acquired  –  (3) –  – 
Unpaid at the end of the year  104  473  –  – 
Paid in advance at the end of the year  (14) (67) –  – 
Cash paid  (676) (369) –  – 
23.5 Reconciliation of dividends paid         
Per statements of changes in equity  (3 748) (4 525) (3 782) (4 860)
Paid by subsidiary companies to minority  (65) (151)    
Cash paid  (3 813) (4 676) (3 782) (4 860)